Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124
Cancers · 13.03.2026 · 18 (6) · 941
DOI: 10.3390/cancers18060941 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancers, online erschienen am 13.03.2026. Verfasst von Bertrand Pourroy und 22 weiteren Autor:innen. Beteiligte Einrichtung: Oncopharma Unit, Hôpitaux Universitaires de Marseille La Timone, 13005 Marseille, France. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BTG Pharmaceuticals.
Abstract (Originalsprache)
Text Correction [...]
Autor:innen und Institutionen
- Oncopharma Unit, Hôpitaux Universitaires de Marseille La Timone, 13005 Marseille, France.
- Pharmacy Service, Reina Sofia University Hospital, 14004 Cordoba, Spain.
- Department of Pediatric Hematology and Oncology, University of Hannover, 30167 Hannover, Germany.
- Lymphoma Unit, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.
- Pediatric Oncology & Hematology, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
- Department of Pediatrics Oncology/Haematology, University of Nottingham, Nottingham NG5 1PB, UK.
ORCID-Profile: Bertrand Pourroy, Maria D Aumente, Christian Koenecke, Martin Stanulla, Andrés J M Ferreri, Thais M Carillo, Madhumita Dandapani, Timothy A Ritzmann, Pere Barba, Etienne Chatelut, Katrina M Ingley, Emma Morris, Elisabeth Schorb, Sven Liebig, Stefan Schwartz, Scott C Howard, Ryan Combs, Nicolás Tentoni, Jennifer Lowe, Gabriela Villanueva, Miriam Hwang, Carmelo Rizzari
Förderung
- BTG Pharmaceuticals
Zitieren
APA
Pourroy, B., Aumente, M. D., Koenecke, C., Stanulla, M., Ferreri, A. J. M., Carillo, T. M., Dandapani, M., Ritzmann, T. A., Barba, P., Chatelut, E., Ingley, K. M., Morris, E., Schorb, E., Liebig, S., Schwartz, S., Howard, S. C., Combs, R., Tentoni, N., Lowe, J., …, & Rizzari, C. (2026). Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124. Cancers, 18(6), 941. https://doi.org/10.3390/cancers18060941
Vancouver
Pourroy B, Aumente MD, Koenecke C, Stanulla M, Ferreri AJM, Carillo TM, et al. Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124. Cancers. 2026;18(6):941. doi:10.3390/cancers18060941
BibTeX
@article{Pourroy2026,
author = {Pourroy, Bertrand and Aumente, Maria D and Koenecke, Christian and Stanulla, Martin and Ferreri, Andrés J M and Carillo, Thais M and Dandapani, Madhumita and Ritzmann, Timothy A and Barba, Pere and Chatelut, Etienne and Ingley, Katrina M and Morris, Emma and Schorb, Elisabeth and Liebig, Sven and Schwartz, Stefan and Howard, Scott C and Combs, Ryan and Tentoni, Nicolás and Lowe, Jennifer and Villanueva, Gabriela and Sampor, Claudia and Hwang, Miriam and Rizzari, Carmelo},
title = {Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124},
journal = {Cancers},
year = {2026},
volume = {18},
number = {6},
pages = {941},
doi = {10.3390/cancers18060941}
}
EUVIMED